ABSTRACT The mechanism by which negatively charged substances such as celite, kaolin, or ellagic acid contribute to the surface-dependent activation of Hageman factor (Factor XII) was studied. Kinetic studies of the proteolytic activation of '514-labeled human Hageman factor by human plasma kallikrein, plasmin, activated Factor XI, and trypsin were performed in the presence and absence of hig molecular, weight kininogen and surface materials such as celite, kaolin, or ellagic acid. The results showed that surface-bound Hageman factor was 500 times more susceptible than soluble Hageman factor to proteolytic activation by kallikrein in the presence of high molecular weight kininogen. Surface binding of Hageman factor enhanced its cleavage by plasmin, activated Factor XI, and trypsin by 100-fold, 30-fold, and 5-fold, respectively. On a molar basis, trypsin was twice as potent as kallikrein in the cleavage of the surface-bound Hageman factor, while plasmin and activated Factor XI were an order of magnitude less potent than kallikrein. Kallikrein even at concentrations as low as 0.5 nM (i.e., 1/1000th of the concentration of prekallikrein' in plasma) was very potent in the limited proteolysis of the surface-boulid Hageman factor. These results suggest that substances classically known as "activating surfaces" promote the activation of Hageman factor indirectly by alerng its structure such that it is much more susceptible to proteolytic activation by otherplasma or cellular proteases.
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Exposure of human plasma to glass, kaolin, celite, or other negatively charged surfaces initiates contact activation reactions that trigger the intrinsic coagulation pathway (1, .2), the kinin-forming pathway (3) , and the fibrinolytic pathway (4, 5) . Proteins that are known to be involved in contact activation of human plasma include Hageman factor (HF, blood coagulation Factor XII) (6) , plasma prekallikrein (Fletcher factor) (7, 8) , coagulation Factor XI (plasma thromboplastin antecedent) (9) , and high molecular weight (Mr) kininogen, which was recognized in studies.of Flaujeac trait (10) , Fitzgerald trait (11, 12) , Williams trait (13) , and "contact activation cofactor" (14) .
For many years it has been assumed, but never directly proven, that HF is directly activated by absorption to negatively charged surfaces (15) . However, in the initial step of contact activation, recent studies using highly purified HF (16, 17) or bovine (18, 19) HF in the absence of other proteins.
These data, together with the observations that surface-bound HF is rapidly cleaved in plasma during contact activation in glass tubes (20) and that HF in solution can be proteolytically activated by plasmin, kallikrein, Factor XIa, or trypsin (21) (22) (23) (24) , stimulated the present quantitative studies of the cleavage of purified human HF by these proteases in the presence and absence of various surface materials and high-Mr kininogen. In this report the limited proteolysis of l25I-labeled HF (125I-HF) was assessed using sodium dodecyl sulfate (NaDodSO4) gel analysis to follow the cleavage of the 80,000 Mr single chain HF zymogen to give fragments of approximately 52,000 and 28,000 Mr.
MATERIALS AND METHODS
Hageman factor was isolated from freshly collected normal human plasma as previously described (25) and gave a single stained protein band on polyacrylamide gels run in the presence of NaDodSO4 (26) . The purified protein had a specific clotting activity of 80 units per mg protein, with 1 clotting unit defined as the amount of activity present in 1 ml of citrated normal human plasma. HF was radiolabeled with 125I using the chloramine-T method (27) . The 125I-HF, containing from 2 to 8 ,uCi/,ug in different preparations, retained its procoagulant activity, assayed as previously described (25) .
Prekallikrein [also known as plasminogen proactivator (28) ], Factor XI, and high-Mr kininogen were isolated from fresh human plasma by reported methods (29) (30) (31) . The specific clotting activities of these three proteins were 19, 220, and 12 clotting units per mg, respectively, as assayed in the appropriate deficient plasmas. Each protein appeared to be greater than 95% homogeneous on NaDodSO4 gels in the presence of reducing agent.
Kallikrein was prepared by activating the purified prekallikrein with purified activated HF in its 28,000-Mr form followed by separation of the kallikrein from the activated HF by DEAE-Sephadex chromatography.* The kallikrein generated in this way retained its full coagulant activity in correcting the coagulation defect of prekallikrein-deficient (Fletcher trait) plasma and possessed full activity in the hydrolysis of the tripeptide subtrate Bz-Pro-Phe-Arg-paranitroanilide.* Factor XIa was generated from purified Factor XI (30) using the method outlined for the activation of prekallikrein. The Factor XIa generated in this way retains full procoagulant activity as assayed in Factor XIa clotting assays. In calculating the molar concentration of each protease, a Mr value of 85,000 was used for prekallikrein, (29) , and 83,000 Mr was used for Factor XIa (30) . In' the latter case it was assumed there are two active sites per Factor XIa molecule of 160,000 Mr.
Plasminogen was isolated from fresh human plasma, and plasmin was generated by passage of the plasminogen over urokinase-agarose beads as previously reported (28) . The The cleavage of 125I-HF in each reaction mixture was assessed using NaDodSO4 gel analysis in the presence of 2-mercaptoethanol (20, 21, 32) . On reduced NaDodSO4 gels, the 125I-HF gave only three peaks, which corresponded to apparent molecular weights of 80,000, 52,000, and 28,000. The percent of HF cleaved was calculated using the integrated radioactivity for each peak and the observation that the disappearance of the 80,000-Mr peak was correlated with the appearance of the 52,000-and 28,000-Mr peaks.
RESULTS
Cleavage of Hageman Factor by Kallikrein. The limited proteolytic cleavage of human HF by different proteases was studied by following the cleavage of the 125I-HF zymogen at 80,000 Mr to give fragments near 5g,000 and 28,000 Mr as assessed using NaDodSO4 gel analysis (20, 21, 32) . The cleavage of 125I-HF by kallikrein was linear with time during the cleavage of greater than 50% of the HF molecules (32) . The initial rate of cleavage of HF was directly proportional to the concentration of kallikrein. In Fig. 1 , the concentration of kallikrein was varied and the percent of HF molecules cleaved during a 9-min period was determined. The effects of the presence or absence of celite and of high-Mr kininogen on this reaction are seen in Fig. 1 . Note that the lower abscissa records the concentration of kallikrein in the absence of celite while the upper abscissa, whose scale differs by 50, reflects the concentration in the presence of celite. A comparison of the initial slopes of the curves in Fig. 1 indicates that, in the absence of high-Mr kininogen, HF bound to celite was 50 times more susceptible to cleavage by kallikrein than HF in solution. High-Mr kininogen further enhanced the susceptibility to cleavage of the surface-bound HF by 10-fold (Fig. 1) , and, therefore, surface plus high-Mr kininogen resulted in a 500-fold difference. However, high-Mr kininogen did not affect the cleavage of HF in solution by kallikrein (Fig. 1) . Results Fig. 2 indicate that surface-bound HF is 100 times more susceptible to cleavage by plasmin than high-Mr kininogen. The final concentrations of reagents in the reaction mixture (0.15 ml) were 63 nM HF, 70 nM high-Mr kininogen (when present), celite (when present) at 3.3 mg/ml, and bovine serum albumin at 0.7 mg/ml. The 0.15 ml was composed of 0.1 ml of Trisbuffered saline, 0.02 ml of storage buffer, and 0.03 ml of 0.1 M TrisCl, pH 7.4. The reaction mixture was incubated for 9 min at 370, and the reaction was terminated as described for Fig. 1 Fig. 3 . These data show that celite-bound HF was cleaved at least 30 times more readily than HF in solution by Factor XIa. High-Mr kininogen did not affect these reactions (Fig. 3) .
Cleavage of Hageman Factor by Trypsin. In studies similar to those described above (Figs. 1-3 (20) . These polypeptides represent The value for kallikrein in the cleavage of surface-bound HF is that observed in the presence of high-Mr kininogen. In the absence of high-Mr kininogen, kallikrein was l/o as potent. For the other enzymes, the presence of high-Mr kininogen did not affect the rates of cleavage of HF.
the two major forms of activated HF, a single chain 28,000-Mr molecule and a disulfide-linked two-chain 80,00Mr molecule containing a heavy chain of 52,000 Mr in addition to the 28,000-Mr polypeptide (20) . These observations on the rapid cleavage of 125I-HF in plasma and the results reported here support the hypothesis that surface binding of HF causes a conformational change in the molecule which results in a structure that is much more susceptible to proteolytic activation (32) . Fig. 4 shows a simple scheme depicting this mechanism. This hypothesis is particularly attractive in helping to explain the role of surface in the activation of HF because studies using [3H]diisopropyl phosphorofluoridate as a quantitative active site titrant of surface-bound HF suggested that no detectable (<0.4%) nonproteolytic activation of HF results simply from surface binding (16) (17) (18) (19) . A proper assessment of possible reciprocal activation mechanisms involving HF and prekallikrein (plasminogen proactivator), Factor XI, and plainogen requires quantitative descriptions and analyses of each of the individual reactions involved. In this regard it is important to note the relative potency of each enzyme required to cleave 10% of available HF molecules as calculated from the data in Figs. 1-3 125I-HF are severely retarded but not absent in prekallikrein-deficient plasma (7, 8, 20) . Given the high sensitivity of surface-bound HF to cleavage of plasmin (Table 1) , it is tempting to speculate that a secondary pathway could involve plasmin.
In contrast to the potency of kallikrein and plasmin in the cleavage of surface-bound HF, rather large percentages of the available Factor XI in plasma would have to be activated in order to have comparable influence (Table 1) . Furthermore, for the cleavage of HF in solution in plasma, the fact that 13-24% of the available plasma plasminogen or prekallikrein needs to be activated to accomplish extensive cleavage (Table  1) suggests that the proteolytic activation of HF in solution by either of these proteases may not be a particularly effective pathway in normal plasma.
Several observations are consistent with the hypothesis that the major pathway for activation of HF during contact activation involves limited proteolysis of surface-bound HF by kallikrein. First, the data reported here emphasize the high sensitivity of surface-bound HF to proteolytic activation (Table  1) . Second, studies of the cleavage of surface-bound and soluble 125I-HF in plasma during contact activation demonstrated that surface-bound HF is rapidly cleaved under conditions in which soluble HF is not cleaved (20) . Third, the surface-bound single chain form of HF does not react with the active site titrant diisopropyl phosphorofluoridate (16) (17) (18) (19) and does not exhibit esterase activity (19) . Fourth, studies of the binding and cleavage of 125I-prekallikrein in plasma during contact activation showed that kallikrein is rapidly generated and that most of the kallikrein is in solution (31; S. D. Revak, B. N. Bouma, C. G. Cochrane, and J. M. Griffin, unpublished data). Hence, soluble kallikrein, which is potent in the cleavage of surfacebound HF, is rapidly generated and readily available in plasma during contact activation. Fifth, the correction of the coagulation defect of prekallikrein-deficient plasma requires the addition of enzymatically active kallikrein as well as kaolin (8, 34, 35) . Thus, reciprocal proteolytic activation of HF and prekallikrein (20, 21, 32, 35) probably represents the major mechanism responsible for contact activation of HF.
The critical question remains; what can provide the triggering proteolytic activity that initiates the cycle of reciprocal proteolytic activation of surface-bound HF and prekallikrein? Only a small trace of active HF or kaflikrein or perhaps another plasma or cellular protease would be needed to initiate the system. Several distinct possibilities can be considered. Plasma might always contain very low levels of active proteases which engage in an omnipresent low-grade expression of plasma proteolytic pathways. This hypothesis, which remains unproven, has been discussed with respect to fibrinogen turnover (36) and to the alternate pathway of complement (37) . The active proteases might be secreted by tissue into the intravascular space under normal circumstances or as a result of injury or foreign stimuli. Alternatively, HF or prekallikrein might be "active zymogens," that is, either one might possess an inherent enzymatic activity analogous to trypsinogen (38, 39) procarboxypeptidase (40) , or Factor VII (41) . The observation that HF does take up [3H]diisopropyl phosphorofluoridate over a period of hours is consistent with this possibility (16, 17) .
